Results 191 to 200 of about 106,917 (289)

Coculture of Primary Motor Neurons and Schwann Cells as a Model for In Vitro Myelination [PDF]

, 2015
Sujin Hyung, Bo Yoon Lee, Jong‐Chul Park, Jinseok Kim, Eun‐Mi Hur, Jun-Kyo Francis Suh   +5 more
openalex   +1 more source

Effects of Methylcobalamin on Mitochondrial Alterations in Schwann Cells Under Oxidative Stress. [PDF]

Biomedicines
Li Q, Liu S, Zhang L, Sun T, Kou Y.
europepmc   +1 more source

Unraveling Lysosomal Exocytosis: From Molecular Mechanisms to Physiological Functions

Traffic, Volume 27, Issue 1, March 2026.
Lysosomal exocytosis is propelled by specific molecular mechanisms that direct its microtubule‐dependent transport and subsequent fusion with the plasma membrane. This process fulfills essential physiological functions such as plasma membrane repair, maintenance of cellular homeostasis, and participation in signal transduction.
Shanshan Jiang, Jingyi Fu, Shan Li, Zehui Li, Qirui Zhao, Yuqi Yin, Mei Yang, Yonghua Wang   +7 more
wiley   +1 more source

KIAA1199: A novel regulator of MEK/ERK‐induced Schwann cell dedifferentiation

, 2017
Angélique Boerboom, Céline Reusch, Alexandra Pieltain, Alain Chariot, Rachelle Franzen   +4 more
openalex   +2 more sources

IDO-Mediated Immune and Metabolic Dysregulation in Schwann Cells Exposed to <i>Mycobacterium leprae</i>. [PDF]

Cells
Rahman AU, Santana RC, de Pinho Pereira MM, Moura CLDS, da Silva DS, Araujo OC, Leal-Calvo T, Espasandin I, da Silva TP, Sarno EN, de Andrade Silva BJ, Menna-Barreto RSF, Jardim MM, de Macedo CS, Lara FA, Pinheiro RO.   +15 more
europepmc   +1 more source

Outcomes following definitive treatment of malignant peripheral nerve sheath tumor are significantly worse for patients with neurofibromatosis type 1: A Canadian Sarcoma Research and Clinical Collaboration study

Cancer, Volume 132, Issue 3, 1 February 2026.
Abstract Background Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive soft tissue sarcomas with a 5‐year survival rate of approximately 50%, secondary to their metastatic potential and resistance to therapy. MPNSTs can arise sporadically, as a late toxicity from therapeutic radiotherapy, or in patients with neurofibromatosis type 1 (NF1).
Rachel E. Aubrey, Pamela Psarianos, Anna T. Santiago, Anthony M. Griffin, Peter C. Ferguson, Abha A. Gupta, Hagit Peretz Soroka, David B. Shultz   +7 more
wiley   +1 more source

Pathology in Practice [PDF]

, 2017
Lofts, R, Priestnall, S L, Summers, B A, Terry, R   +3 more
core   +1 more source

Schwann cells promote the migration and invasion of colorectal cancer cells via the activated NF-κB/IL-8 axis in the tumor microenvironment

, 2022
Shuhai Chen, Mingyou Chen
openalex   +1 more source

Aberrant Molecular Myelin Architecture in Charcot–Marie–Tooth Disease Type 1A and Hereditary Neuropathy With Liability to Pressure Palsies

Glia, Volume 74, Issue 2, February 2026.
PMP22 copy number variation disrupts myelin architecture at SLIs and Nodes of Ranvier. Adherens junction and axoglial domain defects are often more severe in CMT1A than HNPP. Findings support PMP22 functioning as a structural organizer of myelin. ABSTRACT Charcot–Marie–Tooth Disease Type 1A (CMT1A) and Hereditary Neuropathy with Liability to Pressure ...
Kathryn R. Moss, Marvis A. Arowolo, Dave R. Gutierrez, Ahmet Höke   +3 more
wiley   +1 more source

Surgical Management of a Cerebellopontine Angle Tumor After Sudden Onset Facial Paralysis

The Laryngoscope, Volume 136, Issue 2, Page 972-976, February 2026.
Patients with cerebellopontine angle tumors rarely experience acute facial weakness. In this report, we summarize a case where immediate tumor decompression after a patient presented with sudden ipsilateral flaccid facial palsy resulted in complete recovery of facial nerve function, followed by staged gross total tumor resection. Return of facial nerve
Leo L. T. Meller, Douglas M. Bennion, Pradeep Kannampalli, Marc S. Schwartz, Rick A. Friedman   +4 more
wiley   +1 more source